Skip to main content

Unity Biotechnology, Inc.

UBXDelisted
Industry
Pharmaceutical Preparations
SEC CIK
0001463361

Unity Biotechnology, Inc. was delisted in 2025; its insiders filed their last Form 4 on Apr 3, 2025; 35 institutions reported holding it in 13F filings for Q2 2025, worth $987.3K in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Unity Biotechnology, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Unity Biotechnology, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Unity Biotechnology, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Sullivan Lynne MarieCFO & Head of Corp. Dev.98,905Apr 3, 20250
Ghosh AnirvanChief Executive Officer153,454Apr 3, 20250
Nguyen Alexander HieuCLO and Head of Ops48,753Apr 3, 20250
Hashad YehiaDirector–Mar 10, 20250
Grossi FedericoChief Medical Officer–Jan 7, 20250
Berns Paul LDirector–Jun 21, 20240
Samuels Camille DDirector–Jun 21, 20240
Leonard Keith RDirector–Jun 21, 20240
David Nathaniel EDirector–Jun 21, 20240
Roberts Margo RDirector–Jun 21, 20240
O'Neill Gilmore NeilDirector–Jun 21, 20240
Samar Michael P.Director–Jun 21, 20240
Dananberg JamieChief Medical Officer62,817Apr 3, 20230

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Apr 3, 2025 (view filing)Apr 21 dayNguyen Alexander HieuCLO and Head of OpsSSaleCommon Stock, $0.0001 par value−17.9K$1.03−$18.4K−26.8%48.8K after
Apr 3, 2025 (view filing)Apr 21 daySullivan Lynne MarieCFO & Head of Corp. Dev.SSaleCommon Stock, $0.0001 par value−21.9K$1.03−$22.5K−18.1%98.9K after
Apr 3, 2025 (view filing)Apr 21 dayGhosh AnirvanChief Executive OfficerSSaleCommon Stock, $0.0001 par value−96.8K$1.03−$99.7K−38.7%153.5K after
Mar 31, 2025 (view filing)Mar 274 daysNguyen Alexander HieuCLO and Head of OpsSSaleCommon Stock, $0.0001 par value−1.95K$1.16−$2.27K−8.0%22.6K after
Feb 5, 2025 (view filing)Feb 41 daySullivan Lynne MarieCFO & Head of Corp. Dev.SSaleCommon Stock, $0.0001 par value−153$2.23−$341.19−0.3%55.8K after
Feb 5, 2025 (view filing)Feb 41 dayNguyen Alexander HieuCLO and Head of OpsSSaleCommon Stock, $0.0001 par value−164$2.23−$365.72−0.7%24.6K after
Feb 5, 2025 (view filing)Feb 41 dayGhosh AnirvanChief Executive OfficerSSaleCommon Stock, $0.0001 par value−642$2.23−$1.43K−0.8%75.3K after
Nov 6, 2024 (view filing)Nov 42 daysSullivan Lynne MarieCFO & Head of Corp. Dev.SSaleCommon Stock, $0.0001 par value−136$1.29−$175.44−0.2%55.9K after
Nov 6, 2024 (view filing)Nov 42 daysNguyen Alexander HieuChief Legal OfficerSSaleCommon Stock, $0.0001 par value−149$1.29−$192.21−0.6%24.7K after
Nov 6, 2024 (view filing)Nov 42 daysGhosh AnirvanChief Executive OfficerSSaleCommon Stock, $0.0001 par value−432$1.29−$557.28−0.6%75.9K after
Aug 6, 2024 (view filing)Aug 24 daysNguyen Alexander HieuChief Legal OfficerSSaleCommon Stock, $0.0001 par value−154$1.53−$235.62−0.6%24.9K after
Aug 6, 2024 (view filing)Aug 24 daysGhosh AnirvanChief Executive OfficerSSaleCommon Stock, $0.0001 par value−604$1.53−$924.12−0.8%76.3K after
Aug 6, 2024 (view filing)Aug 24 daysSullivan Lynne MarieCFO & Head of Corp. Dev.SSaleCommon Stock, $0.0001 par value−139$1.53−$212.67−0.2%56.1K after
Jun 26, 2024 (view filing)Jun 251 dayNguyen Alexander HieuChief Legal OfficerSSaleCommon Stock, $0.0001 par value−78$1.40−$109.2−0.3%25.0K after
Jun 26, 2024 (view filing)Jun 251 dayGhosh AnirvanChief Executive OfficerSSaleCommon Stock, $0.0001 par value−1.21K$1.40−$1.70K−1.6%76.9K after
Jun 26, 2024 (view filing)Jun 251 daySullivan Lynne MarieCFO & Head of Corp. Dev.SSaleCommon Stock, $0.0001 par value−324$1.40−$453.6−1.0%32.7K after
May 3, 2024 (view filing)May 21 dayGhosh AnirvanChief Executive OfficerSSaleCommon Stock, $0.0001 par value−603$1.55−$934.65−0.8%78.1K after
Feb 5, 2024 (view filing)Feb 23 daysGhosh AnirvanChief Executive OfficerSSaleCommon Stock, $0.0001 par value−680$1.71−$1.16K−0.9%78.7K after
Jan 31, 2024 (view filing)Jan 301 dayGhosh AnirvanChief Executive OfficerSSaleCommon Stock, $0.0001 par value−1.18K$1.71−$2.02K−1.5%79.4K after
Nov 3, 2023 (view filing)Nov 21 dayGhosh AnirvanChief Executive OfficerSSaleCommon Stock, $0.0001 par value−589$1.83−$1.08K−0.7%80.6K after
Oct 31, 2023 (view filing)Oct 301 dayGhosh AnirvanChief Executive OfficerSSaleCommon Stock, $0.0001 par value−1.02K$1.90−$1.95K−1.2%81.2K after
Sep 15, 2023 (view filing)Sep 141 dayGhosh AnirvanChief Executive OfficerSSaleCommon Stock, $0.0001 par value−1.25K$2.47−$3.08K−1.5%82.2K after
Aug 3, 2023 (view filing)Aug 21 dayGhosh AnirvanChief Executive OfficerSSaleCommon Stock, $0.0001 par value−581$2.94−$1.71K−0.7%83.5K after
Aug 1, 2023 (view filing)Jul 311 dayGhosh AnirvanChief Executive OfficerSSaleCommon Stock, $0.0001 par value−1.02K$2.86−$2.92K−1.2%84.0K after
Jun 27, 2023 (view filing)Jun 261 dayGhosh AnirvanChief Executive OfficerSSaleCommon Stock, $0.0001 par value−1.18K$3.20−$3.77K−1.4%85.1K after
Jun 15, 2023 (view filing)Jun 141 dayGhosh AnirvanChief Executive OfficerSSaleCommon Stock, $0.0001 par value−1.21K$3.39−$4.11K−1.4%86.2K after
May 3, 2023 (view filing)May 21 dayGhosh AnirvanChief Executive OfficerSSaleCommon Stock, $0.0001 par value−588$2.17−$1.28K−0.7%87.5K after
May 2, 2023 (view filing)May 11 dayGhosh AnirvanChief Executive OfficerSSaleCommon Stock, $0.0001 par value−1.02K$2.15−$2.19K−92.1%88.05 after
Apr 3, 2023 (view filing)Mar 313 daysGhosh AnirvanChief Executive OfficerSSaleCommon Stock, $0.0001 par value−1.96K$1.70−$3.33K−2.2%89.1K after
Apr 3, 2023 (view filing)Mar 313 daysDananberg JamieChief Medical OfficerSSaleCommon Stock, $0.0001 par value−420$1.70−$714−0.7%62.8K after
Mar 15, 2023 (view filing)Mar 141 dayDananberg JamieChief Medical OfficerSSaleCommon Stock, $0.0001 par value−1.00K$4.00−$4.02K−1.6%63.2K after
Mar 15, 2023 (view filing)Mar 141 dayGhosh AnirvanChief Executive OfficerSSaleCommon Stock, $0.0001 par value−1.21K$4.00−$4.84K−1.3%91.0K after
Feb 3, 2023 (view filing)Feb 21 dayDananberg JamieChief Medical OfficerSSaleCommon Stock, $0.0001 par value−863$4.84−$4.18K−1.3%64.2K after
Feb 3, 2023 (view filing)Feb 21 dayGhosh AnirvanChief Executive OfficerSSaleCommon Stock, $0.0001 par value−2.57K$4.84−$12.5K−2.7%92.2K after
Jan 31, 2023 (view filing)Jan 301 dayGhosh AnirvanChief Executive OfficerSSaleCommon Stock, $0.0001 par value−1.14K$4.45−$5.07K−1.2%94.8K after
Dec 15, 2022 (view filing)Dec 141 dayGhosh AnirvanChief Executive OfficerSSaleCommon Stock, $0.0001 par value−1.27K$2.85−$3.63K−1.3%95.9K after
Dec 15, 2022 (view filing)Dec 141 dayDananberg JamieChief Medical OfficerSSaleCommon Stock, $0.0001 par value−1.02K$2.85−$2.90K−1.5%65.1K after
Nov 4, 2022 (view filing)Nov 31 dayGhosh AnirvanChief Executive OfficerSSaleCommon Stock, $0.0001 par value−1.10K$2.40−$2.64K−1.1%97.2K after
Sep 15, 2022 (view filing)4:11 PM ETSep 141 dayGhosh AnirvanChief Executive OfficerSSaleCommon Stock, $0.0001 par value−13.7K$0.48−$6.58K−1.4%983.2K after
Sep 15, 2022 (view filing)4:10 PM ETSep 141 dayDananberg JamieChief Medical OfficerSSaleCommon Stock, $0.0001 par value−10.9K$0.48−$5.24K−1.6%661.2K after
Aug 2, 2022 (view filing)Aug 11 dayGhosh AnirvanChief Executive OfficerSSaleCommon Stock, $0.0001 par value−10.4K$0.67−$7.00K−1.0%996.9K after
Jun 28, 2022 (view filing)Jun 271 dayDananberg JamieChief Medical OfficerSSaleCommon Stock, $0.0001 par value−4.40K$0.59−$2.59K−0.7%672.1K after
Jun 28, 2022 (view filing)Jun 271 dayGhosh AnirvanChief Executive OfficerSSaleCommon Stock, $0.0001 par value−12.1K$0.59−$7.17K−1.2%1.01M after
Jun 22, 2022 (view filing)Jun 211 dayDananberg JamieChief Medical OfficerSSaleCommon Stock, $0.0001 par value−3.70K$0.62−$2.29K−0.5%676.5K after